Earlier in the day, the stock witnessed a breach early in the session. The stock traded a 52-week high price of Rs 3129.5 and a 52-week low of Rs 2311.3 in Yes. Around 1837 stocks changed hands at the counter until 12:03 PM (IST).
The stock opened at Rs 3118.0 and has touched an intraday high and low of Rs 3118.0 and Rs 3049.0 during the session so far. The accountant traded a price-to-earnings (PE) ratio of 41.27, earnings per share (EPS) of Rs 74.52 and price to book value (PB) of 7.37, while the return on equity (ROE) stood at Rs 21.44 .
Promoter / Holding FII
The developers had a 71.25 percent stake in the company as of August 9, while the FII and MF properties stood at 13.28 percent and 6.66 percent, respectively.
Key finances
With a market capitalization of Rs 52035.99 crore, the company operates in the pharmaceutical industry of India. For the quarter ending June 30, 2021, the company reported consolidated sales of Rs 2,174 crore, 10.02 percent more than Rs 1976.0 crore in the previous quarter and 5.53 percent more than in the same quarter of the previous year. The company reported a net profit of Rs 330.0 crore for the latest quarter, up 2.8 percent from the corresponding quarter last year.
Technical indicators
The stock's Relative Strength Index (RSI) stands at 58.58. The RSI ranges between zero and 100. Traditionally, it is considered an overbought condition when the RSI value is above 70 and an oversold condition when it is below 30. Analysts say that the RSI indicator should not be viewed as In isolation, it may not be enough to accept a trade call, in the same way that a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation index.
